[ad_1]
Jakarta, CNBC Indonesia – China’s Sinovac Covid-19 vaccine has been tested for over a month in Bandung. This test involved 1,620 volunteers. So what is development like?
The head of the research team for the Covid-19 vaccine clinical trial, Professor Kusnandi Rusmil, said that his group had already given the first injection to 1,320 volunteers and the second injection to 660 volunteers.
“It looks like all the injections will be completed next week. Just follow it for 6 months,” he said in an interview with CNBC Indonesia TV on Tuesday (6/10/2020).
Kusnandi Rusmil revealed that the concern in this phase three clinical trial was safety, efficacy and efficiency. Safety in monitoring local reactions, if there is swelling, redness of the skin, etc. One more systemic reaction, as if the volunteers experienced pain, body heat and others.
“The Sinovac vaccine is also being tested in Brazil, India, Bangladesh and Turkey. We will see what the results will be like in other countries. If this vaccine is sold freely, it should have the same results. After that WHO approval. If the WHO says it’s good, it can. sold globally, “he explained.
Kusnandi Rusmil added that clinical trials are expected to be completed by the end of the year and can be used from March 2021. This vaccine will be prioritized for health workers, workers, children, and other productive workers to keep the economy going.
[Gambas:Video CNBC](Roy / Roy)
